Correlation Between Apellis Pharmaceuticals and Viking Therapeutics
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Viking Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Viking Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Viking Therapeutics, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Viking Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Viking Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Viking Therapeutics.
Diversification Opportunities for Apellis Pharmaceuticals and Viking Therapeutics
-0.22 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Apellis and Viking is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Viking Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viking Therapeutics and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Viking Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viking Therapeutics has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Viking Therapeutics go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Viking Therapeutics
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to generate 0.92 times more return on investment than Viking Therapeutics. However, Apellis Pharmaceuticals is 1.09 times less risky than Viking Therapeutics. It trades about 0.24 of its potential returns per unit of risk. Viking Therapeutics is currently generating about -0.25 per unit of risk. If you would invest 2,771 in Apellis Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of 643.00 from holding Apellis Pharmaceuticals or generate 23.2% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. Viking Therapeutics
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| Viking Therapeutics |
Apellis Pharmaceuticals and Viking Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and Viking Therapeutics
The main advantage of trading using opposite Apellis Pharmaceuticals and Viking Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Viking Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viking Therapeutics will offset losses from the drop in Viking Therapeutics' long position.| Apellis Pharmaceuticals vs. Cue Biopharma | Apellis Pharmaceuticals vs. Tff Pharmaceuticals | Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. Inhibrx |
| Viking Therapeutics vs. Cue Biopharma | Viking Therapeutics vs. Tff Pharmaceuticals | Viking Therapeutics vs. Eliem Therapeutics | Viking Therapeutics vs. Inhibrx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |